Calcium chloride
Brand names: Minijet
Calcium chloride is a concentrated intravenous calcium salt used in emergencies for the cardioprotection of severe hyperkalaemia, symptomatic hypocalcaemia, and calcium-channel-blocker or magnesium toxicity, delivering more elemental calcium per volume than calcium gluconate.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Calcium ions restore the transmembrane potential gradient at the myocyte membrane, stabilising cardiac cell excitability, and support normal cardiac and neuromuscular function.
Prescribing in practice
- It is highly irritant and extravasation causes severe tissue necrosis, so it should be given slowly through secure, ideally central, venous access with cardiac monitoring.
- Because it contains substantially more elemental calcium than the equivalent volume of calcium gluconate, the salt must never be assumed interchangeable without recalculation.
- Do not mix or co-administer with bicarbonate- or phosphate-containing solutions, which causes precipitation, and use caution in patients on digoxin where rapid calcium can precipitate arrhythmias.
Monitoring
Use continuous ECG monitoring with checks of serum calcium and potassium, observing the infusion site closely for extravasation.
Counselling the patient
- Flush lines and avoid bicarbonate or phosphate in the same line to prevent precipitation.
- Calcium provides only temporary cardiac protection in hyperkalaemia; treatments to shift and remove potassium must follow.
- Confirm which calcium salt and strength is intended before administration.
Evidence & guidelines
Intravenous calcium for myocardial protection in hyperkalaemia is standard in Resuscitation Council UK and UK renal hyperkalaemia guidance.
Reference: Resus Council UK ALS; UK Renal Association hyperkalaemia; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Boston Syncope Criteria · Syncope
- ARC-HBR Criteria for High Bleeding Risk in PCI · Coronary Artery Disease
- Lead aVR Sign for Left Main / Proximal LAD Occlusion · ECG Interpretation
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- CRASH Score — Chemotherapy Risk Assessment Scale for High-Age · Oncogeriatrics
- Rome IV Diagnostic Criteria for Globus · Functional GI Disorders
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Calcium chloride is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.